0001179110-21-005767.txt : 20210521 0001179110-21-005767.hdr.sgml : 20210521 20210521205744 ACCESSION NUMBER: 0001179110-21-005767 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210519 FILED AS OF DATE: 20210521 DATE AS OF CHANGE: 20210521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Katkin Keith CENTRAL INDEX KEY: 0001314596 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29889 FILM NUMBER: 21950893 MAIL ADDRESS: STREET 1: C/O UROVANT SCIENCES, INC. STREET 2: 5281 CALIFORNIA AVENUE, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92617 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001034842 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943248524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1180 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 MAIL ADDRESS: STREET 1: 1180 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgar.xml FORM 4 - X0306 4 2021-05-19 0 0001034842 RIGEL PHARMACEUTICALS INC RIGL 0001314596 Katkin Keith C/O RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2021-05-19 4 A 0 25000 0 A 25000 D Stock Option (Right to Buy) 3.64 2021-05-19 4 A 0 30000 0 A 2031-05-19 Common Stock 30000 30000 D The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the reporting person's continuous service on the Company's Board of Directors. The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. /s/ Dolly Vance (Attorney-in-Fact) 2021-05-21